Determinants of natural HIV-1 control.

IF 1.9 4区 医学 Q4 IMMUNOLOGY AIDS reviews Pub Date : 2022-04-01 DOI:10.24875/AIDSRev.21000048
Ana Moyano, Thumbi Ndung'u, Jaclyn K. Mann
{"title":"Determinants of natural HIV-1 control.","authors":"Ana Moyano,&nbsp;Thumbi Ndung'u,&nbsp;Jaclyn K. Mann","doi":"10.24875/AIDSRev.21000048","DOIUrl":null,"url":null,"abstract":"<p><p>HIV-1 infection usually progresses to AIDS within 10 years in antiretroviral therapy untreated individuals, but there is a group of infected individuals, known as controllers, who maintain low plasma HIV-1 RNA levels and normal CD4+ T-cell counts for many years. Evidence suggests that the mechanisms of viral control in these individuals are heterogeneous. In this review, we highlight the viral and host factors, particularly host immunological and immunogenetic factors that are associated with controller status. Despite the broad heterogeneity within controllers, there is compelling evidence that cytotoxic CD8+ T lymphocyte responses act as the main driver of control in the majority of these individuals, especially in those with protective HLA-I alleles. Further investigation of controllers without protective HLA-I alleles is required as it seems that this subset exhibits more durable control of HIV-1 disease progression. Understanding the immune defense mechanisms in controllers provides hope for harnessing these responses in the general population, either for protective or therapeutic vaccines or to achieve a functional cure in infected individuals.</p>","PeriodicalId":7685,"journal":{"name":"AIDS reviews","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24875/AIDSRev.21000048","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

HIV-1 infection usually progresses to AIDS within 10 years in antiretroviral therapy untreated individuals, but there is a group of infected individuals, known as controllers, who maintain low plasma HIV-1 RNA levels and normal CD4+ T-cell counts for many years. Evidence suggests that the mechanisms of viral control in these individuals are heterogeneous. In this review, we highlight the viral and host factors, particularly host immunological and immunogenetic factors that are associated with controller status. Despite the broad heterogeneity within controllers, there is compelling evidence that cytotoxic CD8+ T lymphocyte responses act as the main driver of control in the majority of these individuals, especially in those with protective HLA-I alleles. Further investigation of controllers without protective HLA-I alleles is required as it seems that this subset exhibits more durable control of HIV-1 disease progression. Understanding the immune defense mechanisms in controllers provides hope for harnessing these responses in the general population, either for protective or therapeutic vaccines or to achieve a functional cure in infected individuals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
HIV-1自然控制的决定因素。
在未经抗逆转录病毒治疗的个体中,HIV-1感染通常在10年内发展为艾滋病,但有一组被称为控制者的感染者多年来血浆HIV-1 RNA水平较低,CD4+ t细胞计数正常。有证据表明,这些个体的病毒控制机制是不同的。在这篇综述中,我们强调了病毒和宿主因素,特别是宿主免疫和免疫遗传因素与控制状态相关。尽管控制者中存在广泛的异质性,但有令人信服的证据表明,细胞毒性CD8+ T淋巴细胞反应在大多数这些个体中起主要驱动作用,特别是在那些具有保护性hla - 1等位基因的个体中。需要对没有保护性hla -1等位基因的控制者进行进一步研究,因为该亚群似乎对HIV-1疾病进展表现出更持久的控制。了解控制者的免疫防御机制为在普通人群中利用这些反应提供了希望,无论是保护性或治疗性疫苗,还是在受感染个体中实现功能性治愈。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
AIDS reviews
AIDS reviews 医学-传染病学
CiteScore
3.40
自引率
4.50%
发文量
41
审稿时长
>12 weeks
期刊介绍: AIDS Reviews publishes papers reporting original scientific, clinical, epidemiologic and social research which contribute to the overall knowledge of the field of the acquired immunodeficiency syndrome and human retrovirology. Currently, the Journal publishes review articles (usually by invitation, but spontaneous submitted articles will also be considered). Manuscripts submitted to AIDS Reviews will be accepted on the understanding that the authors have not submitted the paper to another journal or published the material elsewhere.
期刊最新文献
Strengthen the doctor-patient relationship and avoid administrative stifling. International HTLV Conference, London, June 3-5, 2024. On the origin of life on earth. HTLV-1/2 infection in Italy: a narrative review of epidemiological studies. Early and contemporary drivers of the HIV-1 group M pandemic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1